Patent Law

I just received notice of the above titled book from industrymatter.  I thought the content was interesting, although it was actually published over a year ago.

In a market environment where competition from generics companies is becoming increasingly aggressive, and the patenting of therapeutics is continually subject to impending legislative change, understanding how to effectively reassess, develop and exploit patent protection strategies is essential in facilitating enhanced market exclusivity and revenue returns over the lifecycles of new drugs. Patent Protection Strategies: Maximizing product revenues is a new report published by Business Insights that examines the need for optimizing and sustaining the patent protection of novel products.

Key findings of this report...

• ANDA reviews are most effectively delayed by pursuing litigation for patent infringement.
• A recently established US Supreme Court ruling will extensively influence future patenting strategies, having been formed in the April 2007 US Supreme Court ruling on patentability involving KSR International Co -v- Teleflex Inc.
• Contingency plans can effectively counter failed or defective patent strategies, as shown in the Claritin and Prozac case studies.
• Successful patent protection strategies can vastly enhance the sustainability of product franchise revenues, significantly exceeding the lifetimes of basic patents. Prominent examples include AstraZeneca's Losec and Nexium, and Amgen's epoetin alfa.
• Holistic investigation of a firm's 'Freedom to Operate' is necessary prior to resource commital in product development or commercialization.

Read more about this book and purchase it here.